AgeX Therapeutics Stock Price - AGE

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.08 -4.3% 1.78 1.905 1.77 1.87 1.86 19:59:37
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
265 35,826 $ 1.84 $ 65,935 94,126 1.16 - 4.99
Last Trade Time Type Quantity Stock Price Currency
19:59:37 2,061 $ 1.78 USD

AgeX Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 67.02M 37.65M $ 331.35M -0.21 - 37.58M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
871.75k $ - 0.00% - -

more financials information »

AgeX Therapeutics News

Loading Messages....

Latest AGE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.801.961.771.8562,122-0.02-1.11%
1 Month1.702.241.601.8381,3040.084.71%
3 Months1.562.241.161.5882,5570.2214.1%
6 Months2.523.141.161.9580,910-0.74-29.37%
1 Year3.974.991.162.8681,532-2.19-55.16%
3 Years1.135.951.133.2099,0490.6557.52%
5 Years1.135.951.133.2099,0490.6557.52%

AgeX Therapeutics Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.


Your Recent History
AMEX
AGE
AgeX Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.